Select Subcommittee Releases Final Report, Culminating More Than Two Years Of Investigations Related To The Nation’s Response To The Coronavirus CrisisThe final report reveals new findings from several of the committee’s investigations—including findings related to the Trump Administration’s failure to recognize and prepare for the threat posed by the coronavirus in early 2020—and includes new information from the Select Subcommittee’s investigations into right-wing purveyors of coronavirus misinformation, and into the practices of for-profit nursing home chains and the toll on their vulnerable residents.
New Select Subcommittee Report Reveals How Fintech Companies Facilitated Fraud In The Paycheck Protection ProgramThe staff report details the poor performance of many financial technology companies in administering the Paycheck Protection Program (PPP), and describes how the investigated companies, despite being tasked with processing PPP applications while screening out those with signs of fraud, abdicated that responsibility—in many cases recklessly—resulting in the approval of large numbers of fraudulent applications.
Select Subcommittee Details Trump Administration’s Assault On CDC And Politicization Of Public Health During The Coronavirus CrisisThis staff report is the third installment in a series of reports documenting the Select Subcommittee’s findings from its investigation into the Trump Administration’s rampant political interference with the federal public health response to the coronavirus pandemic.
Select Subcommittee Uncovers Trump White House’s Extreme Pressure Campaigns Targeting FDA’s Coronavirus ResponseThe report is the second to reveal the Select Subcommittee’s findings from its investigation into the Trump Administration’s political interference with the federal coronavirus response.
Chairs Clyburn, Maloney Reveal That Quality Failures By Emergent BioSolutions Rendered 135 Million Additional Coronavirus Vaccine Doses UnusableThe rejection of the additional 135 million doses brings the total number of doses wasted due to Emergent BioSolutions’ failure to meet or maintain quality standards to over 525 million.
Washington, D.C. (December 15, 2022) – Yesterday, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E. Clyburn, held a hearing on “Preparing for and Preventing the Next Public Health Emergency: Lessons Learned from the Coronavirus Crisis.
Washington, D.C. (December 14, 2022) – Below is Select Subcommittee on the Coronavirus Crisis Chairman James E. Clyburn’s opening statement, as delivered, for a hearing on “Preparing for and Preventing the Next Public Health Emergency: Lessons Learned from the Coronavirus Crisis” with witnesses testifying on the public health and economic impacts of the coronavirus and exploring many of the 30 recommendations for preparing for and preventing future public health emergencies, as detailed in the committee’s final report.
Washington, D.C. (December 14, 2022) – Today, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, published a letter to the editor in the Washington Post, in response to the paper’s December 12 editorial on Republican oversight priorities of the 118th Congress.
Report Waste, Fraud, or Abuse
Chairman Clyburn is interested in any information regarding the waste, fraud, and abuse of taxpayer dollars. We respect your need to remain confidential and will use your contact information only to follow up with you regarding your submission.